Factors Associated With Preference for Long-Acting Injectable Versus Daily Oral Antiretroviral Therapy Among People With HIV: Findings From the SELIGO Study
Findings demonstrate that although there is considerable interest in LAI-ART, HIV treatment modality preferences are multifaceted. Shared decision making can ensure that conversations about ART options consistently address specific factors across diverse groups to facilitate equitable LAI-ART uptake.
Authors
- Robert Agans (ORCID: https://orcid.org/0000-0003-2084-3964)
- Carolina Ruíz (ORCID: https://orcid.org/0000-0001-6691-7274)
- Edward R. Cachay (ORCID: https://orcid.org/0000-0002-2452-7558)
- Madeline Peretti (ORCID: https://orcid.org/0000-0003-3937-8812)
- Laura P Bamford (ORCID: https://orcid.org/0000-0001-5988-8372)
- Jane Fleming (ORCID: https://orcid.org/0000-0002-8127-2061)
- David A. Wohl (ORCID: https://orcid.org/0000-0002-7764-0212)
- Clare Barrington (ORCID: https://orcid.org/0000-0001-7802-4051)
- Deanna Kerrigan (ORCID: https://orcid.org/0000-0001-7401-9159)
- Stephen R. Cole (ORCID: https://orcid.org/0000-0003-2117-1311)
- Mayer Kh
- Breana Uhrig Castonguay
- R. H.
Institutions
- University of North Carolina at Chapel Hill (US)
- Milken Institute (US)
- George Washington University (US)
- University of California San Diego (US)
- Mayo Clinic in Arizona (US)
- Department of Health (ZA)
- Fenway Health (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1097/qai.0000000000003781
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Mental Health